Report Feature
Pharmaceutical Excipient Market Trends and Forecast
The future of the global pharmaceutical excipient market looks promising with opportunities in the oral formulation, tablet, capsule, liquid formulation, topical formulation, and parenteral formulation end use industries. The global pharmaceutical excipient market is expected to reach an estimated $11.9 billion by 2028 with a CAGR of 5.9% from 2023 to 2028. The major drivers for this market are rapid advancement in nano technology along with increasing biopharmaceutical industries, and growing demand for functional excipient and novel therapeutics across the globe.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Pharmaceutical Excipient Market by Segment
The study includes trends and forecast for the global pharmaceutical excipient market by product, functionality, end use industry, and region, as follows:
Pharmaceutical Excipient Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
- Organic Chemicals
-
Oleochemicals
- Fatty Alcohols
- Metal Stearates
- Glycerin
- Other Oleochemicals
-
Carbohydrates
-
Sugars
- Actual Sugars
- Sugar Alcohols
- Artificial Sweetners
- Cellulose
- Microcrystalline cellulose
- Cellulose ethers
- Carboxymethyl cellulose (CMC) and Croscarmellose sodium
- Cellulose esters
- Modified Starch
- Dried Starch
- Converted Starch
- Starches
-
Sugars
-
Petrochemicals
- Glycols
- Povidones
- Mineral Hydrocarbons
- Acrylic Polymers
- Other Petrochemical Excipient
- Proteins
- Other Organic Chemicals
- Inorganic Chemicals
- Calcium Phosphate
- Metal Oxides
- Halites
- Calcium Carbonate
- Calcium Sulphate
- Other Inorganic Chemicals
- Other Chemicals
Pharmaceutical Excipient Market by Functionality [Value ($B) Shipment Analysis from 2017 to 2028]:
- Fillers & Diluents
- Suspending & Viscosity Agents
- Coating Agents
- Binders
- Flavoring Agents & Sweeteners
- Disintegrants
- Colorants
- Lubricants & Glidants
- Preservatives
- Emulsifying Agents
- Other Functionalities
Pharmaceutical Excipient Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
- Oral Formulations
- Tablets
-
Capsules
- Hard-gelatin Capsules
- Soft-gelatin Capsules
- Liquid Formulations
- Topical Formulations
- Parenteral Formulations
- Other Formulations
Pharmaceutical Excipient Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Pharmaceutical Excipient Companies
Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, pharmaceutical excipient companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the pharmaceutical excipient companies profiled in this report include-
Pharmaceutical Excipient Market Insights
- Lucintel forecasts that organic chemicals are expected to witness the highest growth over the forecast period due to its increasing usage in pharmaceutical formulation application owing to its non-toxic nature.
- Within this market, the capsules are expected to witness the highest growth over the forecast period because they are cost effective and can be conveniently used by patients.
- Europe is expected to remain the largest region over the forecast period due to the increasing importance of superior pharmaceutical products and biosimilars and rising government initiatives towards reduction of drug prices.
Features of the Pharmaceutical Excipient Market
- Market Size Estimates: Pharmaceutical excipient market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Pharmaceutical excipient market size by various segments, such as product, functionality, end use industry, and region
- Regional Analysis: Pharmaceutical excipient market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different products, functionalities, end use industries, and regions for the pharmaceutical excipient market.
- Strategic Analysis: This includes M&A, new type development, and competitive landscape for the pharmaceutical excipient market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the pharmaceutical excipient market size?
Answer: The global pharmaceutical excipient market is expected to reach an estimated $11.9 billion by 2028.
Q2. What is the growth forecast for pharmaceutical excipient market?
Answer: The global pharmaceutical excipient market is expected to grow with a CAGR of 5.9% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the pharmaceutical excipient market?
Answer: The major drivers for this market are rapid advancement in nano technology along with increasing biopharmaceutical industry and growing demand for functional excipient and novel therapeutics across the globe.
Q4. What are the major segments for pharmaceutical excipient market?
Answer: The future of the pharmaceutical excipient market looks promising with opportunities in the oral formulation, tablet, capsule, liquid formulation, topical formulation, and parenteral formulation end use industries.
Q5. Who are the key pharmaceutical excipient companies?
Answer: Some of the key pharmaceutical excipient companies are as follows:
Answer: The global pharmaceutical excipient market is expected to reach an estimated $11.9 billion by 2028.
Q2. What is the growth forecast for pharmaceutical excipient market?
Answer: The global pharmaceutical excipient market is expected to grow with a CAGR of 5.9% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the pharmaceutical excipient market?
Answer: The major drivers for this market are rapid advancement in nano technology along with increasing biopharmaceutical industry and growing demand for functional excipient and novel therapeutics across the globe.
Q4. What are the major segments for pharmaceutical excipient market?
Answer: The future of the pharmaceutical excipient market looks promising with opportunities in the oral formulation, tablet, capsule, liquid formulation, topical formulation, and parenteral formulation end use industries.
Q5. Who are the key pharmaceutical excipient companies?
Answer: Some of the key pharmaceutical excipient companies are as follows:
- Ashland Global Holdings
- BASF SE
- International Flavors & Fragrances
- Evonik Industries AG
- Roquette Freres
Q6. Which pharmaceutical excipient segment will be the largest in future?
Answer: Lucintel forecasts that organic chemicals are expected to witness the highest growth over the forecast period due to its increasing usage in pharmaceutical formulation application owing to its non-toxic nature.
Q7. In pharmaceutical excipient market, which region is expected to be the largest in next 5 years?
Answer: Europe is expected to remain the largest region over the forecast period due to the increasing importance of superior pharmaceutical products and biosimilars and rising government initiatives towards reduction of drug prices.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Answer: Lucintel forecasts that organic chemicals are expected to witness the highest growth over the forecast period due to its increasing usage in pharmaceutical formulation application owing to its non-toxic nature.
Q7. In pharmaceutical excipient market, which region is expected to be the largest in next 5 years?
Answer: Europe is expected to remain the largest region over the forecast period due to the increasing importance of superior pharmaceutical products and biosimilars and rising government initiatives towards reduction of drug prices.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
